SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011386
Filing Date
2021-08-12
Accepted
2021-08-12 10:01:33
Documents
86
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q casi-20210630x10q.htm   iXBRL 10-Q 1745330
2 EX-10.1 casi-20210630xex10d1.htm EX-10.1 84162
3 EX-10.2 casi-20210630xex10d2.htm EX-10.2 92499
4 EX-10.3 casi-20210630xex10d3.htm EX-10.3 78707
5 EX-10.4 casi-20210630xex10d4.htm EX-10.4 88563
6 EX-31.1 casi-20210630xex31d1.htm EX-31.1 12953
7 EX-31.2 casi-20210630xex31d2.htm EX-31.2 12787
8 EX-32.1 casi-20210630xex32d1.htm EX-32.1 7179
9 EX-32.2 casi-20210630xex32d2.htm EX-32.2 7234
  Complete submission text file 0001558370-21-011386.txt   7820829

Data Files

Seq Description Document Type Size
10 EX-101.SCH casi-20210630.xsd EX-101.SCH 66507
11 EX-101.CAL casi-20210630_cal.xml EX-101.CAL 54348
12 EX-101.DEF casi-20210630_def.xml EX-101.DEF 206751
13 EX-101.LAB casi-20210630_lab.xml EX-101.LAB 464929
14 EX-101.PRE casi-20210630_pre.xml EX-101.PRE 399586
15 EXTRACTED XBRL INSTANCE DOCUMENT casi-20210630x10q_htm.xml XML 1232900
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 211165771
SIC: 2836 Biological Products, (No Diagnostic Substances)